Avidity Biosciences
RNA
#1868
Rank
ยฃ7.98 B
Marketcap
ยฃ53.03
Share price
0.00%
Change (1 day)
103.94%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: ยฃ7.98 Billion

As of February 2026 Avidity Biosciences has a market cap of ยฃ7.98 Billion. This makes Avidity Biosciences the world's 1868th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ7.98 B-1%
2025ยฃ8.07 B181.91%
2024ยฃ2.86 B408.97%
2023ยฃ0.56 B-53.86%
2022ยฃ1.21 B47.61%
2021ยฃ0.82 B17.54%
2020ยฃ0.70 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Avidity Biosciences was reported to be:

ยฃ7.98 Billion
by Nasdaq info icon info icon
ยฃ7.98 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
ยฃ109.84 B 1,274.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ76.19 B 853.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
ยฃ1.55 B-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
ยฃ4.43 B-44.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
ยฃ0.10 B-98.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ0.59 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
ยฃ7.98 B-0.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ2.18 B-72.68%๐Ÿ‡บ๐Ÿ‡ธ USA